RELATED: Realities of life on GLP-1s for weight loss: What doctors say you can expect Our Sources Interview with Kirk Habegger, a professor of endocrinology, diabetes and metabolism at The University of Alabama at Birmingham, June 29, 2026 Interview with Arthur Caplan, a retired professor in the Division of Medical Ethics at the NYU Grossman School of Medicine, June 29, 2026 Interview with Sean Turbeville, a biotechnology executive and creator of the regulatory resource the Global Guide to Compassionate Use Programs, June 29, 2026 Eli Lilly, What to know about retatrutide: An investigational triple hormone receptor agonist , June 6, 2026 STAT, Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient
Your Health Magazine Health Information Team More Weight Control, Nutrition & Exercise Articles Optimal Injection Locations for GLP-1 Therapy: A Comprehensive Guide Managing type 2 diabetes often involves the use of medications to maintain blood glucose levels
One way the drug works is by slowing down the emptying of food in the stomach to the small intestines
That can feel empowering
Ann Intern Med 176(3):427429
